DE1543270A1 - Verfahren zur Herstellung von delta?(10)-3-Desoxosteroiden - Google Patents

Verfahren zur Herstellung von delta?(10)-3-Desoxosteroiden

Info

Publication number
DE1543270A1
DE1543270A1 DE19651543270 DE1543270A DE1543270A1 DE 1543270 A1 DE1543270 A1 DE 1543270A1 DE 19651543270 DE19651543270 DE 19651543270 DE 1543270 A DE1543270 A DE 1543270A DE 1543270 A1 DE1543270 A1 DE 1543270A1
Authority
DE
Germany
Prior art keywords
group
dia
keto
hydroxy
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19651543270
Other languages
German (de)
English (en)
Inventor
De Jongh Hendrik Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Publication of DE1543270A1 publication Critical patent/DE1543270A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19651543270 1964-06-17 1965-06-04 Verfahren zur Herstellung von delta?(10)-3-Desoxosteroiden Pending DE1543270A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6406849A NL6406849A (ja) 1964-06-17 1964-06-17

Publications (1)

Publication Number Publication Date
DE1543270A1 true DE1543270A1 (de) 1969-07-31

Family

ID=19790327

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19651543270 Pending DE1543270A1 (de) 1964-06-17 1965-06-04 Verfahren zur Herstellung von delta?(10)-3-Desoxosteroiden

Country Status (9)

Country Link
BE (1) BE665515A (ja)
BR (1) BR6570426D0 (ja)
CH (1) CH487874A (ja)
DE (1) DE1543270A1 (ja)
DK (2) DK121510B (ja)
FR (1) FR1604116A (ja)
GB (1) GB1107553A (ja)
NL (1) NL6406849A (ja)
SE (1) SE336789B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6901532A (ja) * 1969-01-30 1970-08-03
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators

Also Published As

Publication number Publication date
BR6570426D0 (pt) 1973-08-14
CH487874A (de) 1970-03-31
SE336789B (ja) 1971-07-19
NL6406849A (ja) 1965-12-20
DK125773B (da) 1973-05-07
DK121510B (da) 1971-10-25
GB1107553A (en) 1968-03-27
FR1604116A (en) 1971-07-12
BE665515A (ja)

Similar Documents

Publication Publication Date Title
DE1593427A1 (de) Verfahren zur Herstellung von Steroiden
DE2301317C2 (de) Alkylierte 3,20-Diketo-Δ↑4↑-steroide der Pregnanreihe und Verfahren zu deren Herstellung
DE1468035A1 (de) Verfahren zur Herstellung von 19-Alkylsteroiden
DE1543270A1 (de) Verfahren zur Herstellung von delta?(10)-3-Desoxosteroiden
DE1468410A1 (de) Verfahren zur Herstellung von 16-Methylensteroiden
DE1181705B (de) Verfahren zur Herstellung von 16ß-niedrig-Alkylcortisonen, -hydrocortisonen, -prednisonen und -prednisolonen sowie von deren 9 alpha-Halogenderivaten und 21-Estern
EP0440752B1 (de) Verfahren zur herstellung von 3-desoxy-4-en-steroiden
CH624684A5 (ja)
CH550156A (de) Verfahren zur herstellung von 3,6-dihydroxy-(delta)5(10)-steroiden.
US3312720A (en) 3-desoxy-19-nor-androstenes
CH498819A (de) Verfahren zur Herstellung von Steroidketonen mit 17- oder 17a-Halogenalkinylgruppen
DE1593505C3 (ja)
DE957661C (de) Verfahren zur Herstellung von 17-Oxy-20-keto-21acyl-oxypregnanen
DE1793687C3 (de) Verfahren zur Herstellung von Steroidverbindungen. Ausscheidung aus: 1493108
DE1264441B (de) Verfahren zur Herstellung von 17alpha-AEthinyl-delta 5(10-19-nor-androsten-17beta-ol-3-on und 17alpha-AEthynil-19-nor-testosteron sowie dessen Estern
DE1215147B (de) Verfahren zur Herstellung von 19-Norsteroiden der Androstanreihe
DE1493108C (de) Steroidverbindungen
DE1493163C3 (de) nalpha-Äthinyl-ie-methyl-Delta hoch 4-östren-3 beta-17 betadiole, Verfahren zu deren Herstellung sowie diese enthaltende Mittel
DE1227901B (de) Verfahren zur Herstellung von 3-Desoxysteroiden der Androstanreihe
DE1194848B (de) Verfahren zur Herstellung von Steroiden der Androstanreihe
DE1593182A1 (de) Verfahren zur Herstellung von 6alpha-methyl-oestrenverbindungen
DE1182229B (de) Verfahren zur Herstellung von 7-Methylsteroiden
DE1543469A1 (de) Neue Steroid-derivate und Verfahren zu deren Herstellung
DE1237566B (de) Verfahren zur Herstellung von delta 5-3-Oxosteroiden
DE2158837A1 (de) 6alpha,7alpha-Dimethylsteroide und Verfahren zu deren Herstellung